Skip to main navigation Skip to search Skip to main content

Valutazione HTA di un farmaco innovativo per il trattamento dell' osteoporosi post-menopausale: il denosumab

Translated title of the contribution: HTA evaluation of an innovative drug for the treatment of post-menopausal osteoporosis: denosumab

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Translated title of the contributionHTA evaluation of an innovative drug for the treatment of post-menopausal osteoporosis: denosumab
Original languageItalian
Title of host publicationAtti del IV Congresso Nazionale Società Italiana di Health Technology Assessment (SIHTA) “HTA è qualità dei servizi sanitari”
PublisherIniziative Sanitarie
Pages11-11
Number of pages1
Publication statusPublished - 2011

Keywords

  • Health Technology Assessment
  • Osteoporosis
  • denosumab

Cite this